|Home||» Products||» Pharmaceutical Medicine||» Adalimumab|
Adalimumab, Humira Adalimumab is the third TNF inhibitor, after infliximab and etanercept, to be approved in the United States .
Humira (adalimumab) reduces the effects of a substance in the body that can cause inflammation. Humira is used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, and and a chronic skin condition called hidradenitis suppurativa.
MEDIFLORA PHARMASI All Rights Reserved.